---
figid: PMC3430731__WJBC-3-167-g001
figlink: /pmc/articles/PMC3430731/figure/F1/
number: F1
caption: 'Signaling pathways regulating lipogenesis in cancer cells. This scheme represents
  the main regulation of lipogenesis in cancer cells. Lipid metabolizing enzymes are
  regulated by oncogenic signals. Growth factor-activated PI3K-AKT or hypoxia-induced
  HIF stimulates glucose transporters and hexokinases to promote glycolysis, providing
  more synthetic precursors for fatty acid synthesis. Akt also activates the lipogenic
  enzyme activity and expression through direct phosphorylation or SREBP-mediated
  transcription enhancement of lipogenic genes. The tumor suppressor, p53, plays a
  role in glucose uptake, pentose phosphate pathway and anaplerosis of citrate. As
  a transcription factor, p53 also enhances the expression of glucose transporters
  and Glutaminase 2. The inductive effect on TIGAR and the activity inhibition of
  G6PDH caused by catalytic effect of p53 constitute a complex regulation on pentose
  phosphate pathway imposed by p53. LKB1/AMPK pathway, the master regulator in cellular
  energetic metabolism, modulates ACC activity either by direct phosphorylation or
  through SREBP-1. Myc is involved in lipid metabolism and promotes citrate anaplerosis
  through increasing glutamine transporters and glutaminase 2 expression. The activity
  and expression of lipogenic enzyme, ACL, ACC and FASN, are regulated at multiple
  levels through mTOR, MAPK, USP2a, Sp1, etc. Glut: Glucose transporter; HK: Hexokinase;
  G-6-P: Glucose-6-phosphate; F-6-P: Fructose-6-phosphate; FBP: Fructose-1,6-bisphosphate;
  GFR: Growth factors receptor; PI3K: Phosphatidylinositol 3-kinase; MAPK: Mitogen
  activated protein kinase; SREBP-1: Sterol-regulatory element-binding protein-1;
  TIGAR: TP53-induced glycolysis and apoptosis regulator; OAA: Oxaloacetate; ACL:
  ATP citrate lyase; ACC: Acetyl-CoA carboxylase; FASN: Fatty acid synthase; FA: Fatty
  acids; G6PDH: Glucose-6-phosphate dehydrogenase; αKG: α-ketoglutarate; PFK: Phosphofructokinase;
  NADPH: Nicotinamide adenine dinucleotide phosphate; Mal: Malate; ME: Malic enzyme;
  Ac-CoA: Acetyl-CoA; mTOR: Mammalian target of rapamycin; USP2a: Ubiquitin-specific
  protease-2a; IDH3: Isocitrate dehydrogenase 3; R-5-P: Ribose-5-phosphate; HIF: Hypoxia-inducible
  factor; EMS: Extracellular microenvironmental stress.'
pmcid: PMC3430731
papertitle: Dysregulated lipid metabolism in cancer.
reftext: Feng Zhang, et al. World J Biol Chem. 2012 Aug 26;3(8):167-174.
pmc_ranked_result_index: '72936'
pathway_score: 0.9407107
filename: WJBC-3-167-g001.jpg
figtitle: Signaling pathways regulating lipogenesis in cancer cells
year: '2012'
organisms:
- Homo sapiens
ndex: c7a23153-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3430731__WJBC-3-167-g001.html
  '@type': Dataset
  description: 'Signaling pathways regulating lipogenesis in cancer cells. This scheme
    represents the main regulation of lipogenesis in cancer cells. Lipid metabolizing
    enzymes are regulated by oncogenic signals. Growth factor-activated PI3K-AKT or
    hypoxia-induced HIF stimulates glucose transporters and hexokinases to promote
    glycolysis, providing more synthetic precursors for fatty acid synthesis. Akt
    also activates the lipogenic enzyme activity and expression through direct phosphorylation
    or SREBP-mediated transcription enhancement of lipogenic genes. The tumor suppressor,
    p53, plays a role in glucose uptake, pentose phosphate pathway and anaplerosis
    of citrate. As a transcription factor, p53 also enhances the expression of glucose
    transporters and Glutaminase 2. The inductive effect on TIGAR and the activity
    inhibition of G6PDH caused by catalytic effect of p53 constitute a complex regulation
    on pentose phosphate pathway imposed by p53. LKB1/AMPK pathway, the master regulator
    in cellular energetic metabolism, modulates ACC activity either by direct phosphorylation
    or through SREBP-1. Myc is involved in lipid metabolism and promotes citrate anaplerosis
    through increasing glutamine transporters and glutaminase 2 expression. The activity
    and expression of lipogenic enzyme, ACL, ACC and FASN, are regulated at multiple
    levels through mTOR, MAPK, USP2a, Sp1, etc. Glut: Glucose transporter; HK: Hexokinase;
    G-6-P: Glucose-6-phosphate; F-6-P: Fructose-6-phosphate; FBP: Fructose-1,6-bisphosphate;
    GFR: Growth factors receptor; PI3K: Phosphatidylinositol 3-kinase; MAPK: Mitogen
    activated protein kinase; SREBP-1: Sterol-regulatory element-binding protein-1;
    TIGAR: TP53-induced glycolysis and apoptosis regulator; OAA: Oxaloacetate; ACL:
    ATP citrate lyase; ACC: Acetyl-CoA carboxylase; FASN: Fatty acid synthase; FA:
    Fatty acids; G6PDH: Glucose-6-phosphate dehydrogenase; αKG: α-ketoglutarate; PFK:
    Phosphofructokinase; NADPH: Nicotinamide adenine dinucleotide phosphate; Mal:
    Malate; ME: Malic enzyme; Ac-CoA: Acetyl-CoA; mTOR: Mammalian target of rapamycin;
    USP2a: Ubiquitin-specific protease-2a; IDH3: Isocitrate dehydrogenase 3; R-5-P:
    Ribose-5-phosphate; HIF: Hypoxia-inducible factor; EMS: Extracellular microenvironmental
    stress.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKR1B10
  - ACLY
  - PAEP
  - ACACA
  - PIK3CB
  - PIK3CD
  - PRKAB2
  - PIK3CG
  - PRKAB1
  - PFKM
  - TP53
  - SLC38A5
  - MAPK1
  - MAPK12
  - MYC
  - PIK3R6
  - ACACB
  - MAL
  - PRKAG1
  - MTOR
  - FASN
  - PRKAA2
  - MAPK9
  - MAPK11
  - PRKAG3
  - AKT3
  - PKM
  - STK11
  - SLC1A5
  - MAPK10
  - TP73
  - AKT1
  - PIK3R4
  - THRSP
  - MAPK13
  - PRKAA1
  - PIK3R3
  - HIF1A
  - MAPK14
  - SREBF1
  - PIK3R5
  - MAPK8
  - PRKAG2
  - ARNT
  - PIK3CA
  - ARNT2
  - TIGAR
  - EPAS1
  - FBP1
  - SLC2A1
  - MAPK3
  - ARNTL
  - HIF3A
  - Fatty acids
  - Glucose
  - Glutamine
  - Citrate Isocitrate
  - Malonyl-CoA
  - Pyruvate
  - Glutamate
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKR1B10
  symbol: AKR1B10
  source: hgnc_symbol
  hgnc_symbol: AKR1B10
  entrez: '57016'
- word: ACL)
  symbol: ACL
  source: hgnc_alias_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: PEP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: PFK1
  symbol: PFK-1
  source: hgnc_alias_symbol
  hgnc_symbol: PFKM
  entrez: '5213'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: SLC38A5/
  symbol: SLC38A5
  source: hgnc_symbol
  hgnc_symbol: SLC38A5
  entrez: '92745'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: Mal
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FASN
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: SLC1A5
  symbol: SLC1A5
  source: hgnc_symbol
  hgnc_symbol: SLC1A5
  entrez: '6510'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: SpiSPOT14p63/p73
  symbol: P73
  source: hgnc_alias_symbol
  hgnc_symbol: TP73
  entrez: '7161'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: SPOT14
  symbol: SPOT14
  source: hgnc_alias_symbol
  hgnc_symbol: THRSP
  entrez: '7069'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: SREBP-1
  symbol: SREBP1
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: TIGAR
  symbol: TIGAR
  source: hgnc_symbol
  hgnc_symbol: TIGAR
  entrez: '57103'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: FBP
  symbol: FBP
  source: hgnc_prev_symbol
  hgnc_symbol: FBP1
  entrez: '2203'
- word: Glut
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
chemicals:
- word: Fatty acids
  source: MESH
  identifier: D005227
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glutamine
  source: MESH
  identifier: D005973
- word: Citrate Isocitrate
  source: MESH
  identifier: D007523
- word: Malonyl-CoA
  source: MESH
  identifier: D008316
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Glutamate
  source: MESH
  identifier: D018698
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3430731__F1
redirect_from: /figures/PMC3430731__F1
figtype: Figure
---
